CHIARAVALLOTI, AGOSTINO

Nome completo

Afferenza

Dipartimento di Medicina sperimentale e clinica

Mostra records

Risultati 1 - 14 di 14 (tempo di esecuzione: 0.002 secondi).

Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective study

2022-01-01 Fernandes, Mariana; Manfredi, Natalia; Aluisantonio, Lavinia; Franchini, Flaminia; Chiaravalloti, Agostino; Izzi, Francesca; Di Santo, Simona; Schillaci, Orazio; Mercuri, Nicola Biagio; Placidi, Fabio; Liguori, Claudio

Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT?

2015-01-01 Di Biagio, D.; Chiaravalloti, A.; Tavolozza, M.; Abbatiello, P.; Schillaci, O.

Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: Molecular imaging with 123I-MIBG

2012-01-01 Chiaravalloti, A.; Stefani, A.; Tavolozza, M.; Pierantozzi, M.; Di Biagio, D.; Olivola, E.; Di Pietro, B.; Stampanoni, M.; Danieli, R.; Simonetti, G.; Stanzione, P.; Schillaci, O.

Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECT

2011-01-01 Schillaci, O.; Chiaravalloti, A.; Pierantozzi, M.; Di Pietro, B.; Koch, G.; Bruni, C.; Stanzione, P.; Stefani, A.

Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease

2014-01-01 Chiaravalloti, A.; Stefani, A.; Fiorentini, A.; Lacanfora, A.; Stanzione, P.; Schillaci, O.

Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment

2015-01-01 Chiaravalloti, A.; Fiorentini, A.; Villani, V.; Carapella, C.; Pace, A.; Di Pietro, B.; Di Russo, C.; Palumbo, B.; Floris, R.; Schillaci, O.

Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/18F-FDG-PET Study

2023-01-01 Bonomi, C. G.; Chiaravalloti, A.; Camedda, R.; Ricci, F.; Mercuri, N. B.; Schillaci, O.; Koch, G.; Martorana, A.; Motta, C.

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases

2021-01-01 Sala, Arianna; Caminiti, Silvia Paola; Presotto, Luca; Pilotto, Andrea; Liguori, Claudio; Chiaravalloti, Agostino; Garibotto, Valentina; Frisoni, Giovanni Battista; D’Amelio, Marcello; Paghera, Barbara; Schillaci, Orazio; Mercuri, Nicola; Padovani, Alessandro; Perani, Daniela

Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario

2020-01-01 Vanni, Gianluca; Pellicciaro, Marco; Materazzo, Marco; Bruno, Valentina; Oldani, Chiara; Pistolese, Chiara Adriana; Buonomo, Chiara; Caspi, Jonathan; Gualtieri, Paola; Chiaravalloti, Agostino; Palombi, Leonardo; Piccione, Emilio; Buonomo, Oreste Claudio

Molecular and Metabolic Imaging of Castration-Resistant Prostate Cancer: State of Art and Future Prospects

2022-01-01 Filippi, L.; Chiaravalloti, A.; Basile, P.; Schillaci, O.; Bagni, O.

Reconstruction-dependent differences in brain [18F]FDG PET: a large-scale same-acquisition comparison of Q.Clear and VUE Point FX

2026-01-01 Chiaravalloti, A.; Di Biagio, D.; D'Ascenzo, N.; Urbano, N.; Martorana, A.; Schillaci, O.

Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship

2015-01-01 Chiaravalloti, A.; Schillaci, O.

Thalamic 123I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression

2012-01-01 Schillaci, O.; Chiaravalloti, A.; Di Pietro, B.; Stefani, A.

WIDEN: A tool for medical image management in multicenter clinical trials

2014-01-01 Chauvie, S.; Biggi, A.; Stancu, A.; Cerello, P.; Cavallo, A.; Fallanca, F.; Ficola, U.; Gregianin, M.; Guerra, U. P.; Chiaravalloti, A.; Schillaci, O.; Gallamini, A.

Titolo	Data di pubblicazione	Autore(i)
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective study	1-gen-2022	Fernandes, Mariana; Manfredi, Natalia; Aluisantonio, Lavinia; Franchini, Flaminia; Chiaravalloti, Agostino; Izzi, Francesca; Di Santo, Simona; Schillaci, Orazio; Mercuri, Nicola Biagio; Placidi, Fabio; Liguori, Claudio
Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT?	1-gen-2015	Di Biagio, D.; Chiaravalloti, A.; Tavolozza, M.; Abbatiello, P.; Schillaci, O.
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: Molecular imaging with 123I-MIBG	1-gen-2012	Chiaravalloti, A.; Stefani, A.; Tavolozza, M.; Pierantozzi, M.; Di Biagio, D.; Olivola, E.; Di Pietro, B.; Stampanoni, M.; Danieli, R.; Simonetti, G.; Stanzione, P.; Schillaci, O.
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECT	1-gen-2011	Schillaci, O.; Chiaravalloti, A.; Pierantozzi, M.; Di Pietro, B.; Koch, G.; Bruni, C.; Stanzione, P.; Stefani, A.
Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease	1-gen-2014	Chiaravalloti, A.; Stefani, A.; Fiorentini, A.; Lacanfora, A.; Stanzione, P.; Schillaci, O.
Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment	1-gen-2015	Chiaravalloti, A.; Fiorentini, A.; Villani, V.; Carapella, C.; Pace, A.; Di Pietro, B.; Di Russo, C.; Palumbo, B.; Floris, R.; Schillaci, O.
Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/18F-FDG-PET Study	1-gen-2023	Bonomi, C. G.; Chiaravalloti, A.; Camedda, R.; Ricci, F.; Mercuri, N. B.; Schillaci, O.; Koch, G.; Martorana, A.; Motta, C.
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases	1-gen-2021	Sala, Arianna; Caminiti, Silvia Paola; Presotto, Luca; Pilotto, Andrea; Liguori, Claudio; Chiaravalloti, Agostino; Garibotto, Valentina; Frisoni, Giovanni Battista; D’Amelio, Marcello; Paghera, Barbara; Schillaci, Orazio; Mercuri, Nicola; Padovani, Alessandro; Perani, Daniela
Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario	1-gen-2020	Vanni, Gianluca; Pellicciaro, Marco; Materazzo, Marco; Bruno, Valentina; Oldani, Chiara; Pistolese, Chiara Adriana; Buonomo, Chiara; Caspi, Jonathan; Gualtieri, Paola; Chiaravalloti, Agostino; Palombi, Leonardo; Piccione, Emilio; Buonomo, Oreste Claudio
Molecular and Metabolic Imaging of Castration-Resistant Prostate Cancer: State of Art and Future Prospects	1-gen-2022	Filippi, L.; Chiaravalloti, A.; Basile, P.; Schillaci, O.; Bagni, O.
Reconstruction-dependent differences in brain [18F]FDG PET: a large-scale same-acquisition comparison of Q.Clear and VUE Point FX	1-gen-2026	Chiaravalloti, A.; Di Biagio, D.; D'Ascenzo, N.; Urbano, N.; Martorana, A.; Schillaci, O.
Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin’s lymphoma: the total amount of uptake may play a role in the inverse relationship	1-gen-2015	Chiaravalloti, A.; Schillaci, O.
Thalamic 123I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression	1-gen-2012	Schillaci, O.; Chiaravalloti, A.; Di Pietro, B.; Stefani, A.
WIDEN: A tool for medical image management in multicenter clinical trials	1-gen-2014	Chauvie, S.; Biggi, A.; Stancu, A.; Cerello, P.; Cavallo, A.; Fallanca, F.; Ficola, U.; Gregianin, M.; Guerra, U. P.; Chiaravalloti, A.; Schillaci, O.; Gallamini, A.